Thirty eyes of 30 patients with medically uncontrolled primary and secondary glaucoma under maximal tolerated medical therapy were enrolled to undergo UCP treatment with the EyeOP1 device.
We evaluated all patients before treatment and at 1, 4, 10 days and each month until 1 year after the last treatment. The treatment was repeated after 4 months if the IOP was > 21 mm Hg without major complications.
Complete success was defined as a final IOP> 5 mm Hg and ≤ 21 mm Hg without hypotensive medications adjunction and without major or vision-threatening complications. A maximum of three procedures were performed.
Student’s t-test was used to compare means and percentages and the statistical significance was set at p < 0.01.